ATE167628T1 - Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion - Google Patents

Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion

Info

Publication number
ATE167628T1
ATE167628T1 AT93910701T AT93910701T ATE167628T1 AT E167628 T1 ATE167628 T1 AT E167628T1 AT 93910701 T AT93910701 T AT 93910701T AT 93910701 T AT93910701 T AT 93910701T AT E167628 T1 ATE167628 T1 AT E167628T1
Authority
AT
Austria
Prior art keywords
compositions
methods
diseases associated
treating diseases
immune function
Prior art date
Application number
AT93910701T
Other languages
English (en)
Inventor
Ellis L Kline
Original Assignee
Molecular Rx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Rx Inc filed Critical Molecular Rx Inc
Application granted granted Critical
Publication of ATE167628T1 publication Critical patent/ATE167628T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07006—DNA-directed RNA polymerase (2.7.7.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93910701T 1992-04-22 1993-04-21 Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion ATE167628T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87196892A 1992-04-22 1992-04-22
US4661193A 1993-04-19 1993-04-19

Publications (1)

Publication Number Publication Date
ATE167628T1 true ATE167628T1 (de) 1998-07-15

Family

ID=26724124

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93910701T ATE167628T1 (de) 1992-04-22 1993-04-21 Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion

Country Status (8)

Country Link
US (2) US5804188A (de)
EP (1) EP0642333B1 (de)
JP (1) JP3468519B2 (de)
CN (1) CN1091316A (de)
AT (1) ATE167628T1 (de)
DE (1) DE69319341T2 (de)
IL (1) IL105498A (de)
WO (1) WO1993020803A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071942A (en) * 1996-05-14 2000-06-06 Maxim Pharmaceuticals, Inc. Elevation of circulating blood histamine levels
US5961969A (en) * 1996-05-14 1999-10-05 Maxim Pharmaceuticals, Inc. Stable circulating histamine levels
US20060024301A1 (en) * 1997-02-25 2006-02-02 Corixa Corporation Prostate-specific polypeptides and fusion polypeptides thereof
US20030185830A1 (en) * 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20060269532A1 (en) * 1997-02-25 2006-11-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7048931B1 (en) * 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US9028882B2 (en) 2005-05-02 2015-05-12 4Life Patents, Llc Nutraceutical gels
TWI380821B (zh) * 2005-05-02 2013-01-01 富萊福專利公司 轉移因子製備物及相關的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294818A (en) * 1979-07-30 1981-10-13 University Patents, Inc. Methods and materials for detection of multiple sclerosis
US4582793A (en) * 1982-10-29 1986-04-15 Research Corporation Anti-RNA polymerase I antibody test for the diagnosis of rheumatological diseases
US4751181A (en) * 1984-12-31 1988-06-14 Duke University Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
US5077211A (en) * 1988-07-06 1991-12-31 Applied Genetics, Inc. Purification and administration of dna repair enzymes
US5116615A (en) * 1989-01-27 1992-05-26 Immunolytics, Inc. Method for treating benign prostatic hypertrophy

Also Published As

Publication number Publication date
IL105498A (en) 1998-02-08
DE69319341D1 (de) 1998-07-30
EP0642333A1 (de) 1995-03-15
DE69319341T2 (de) 1999-02-11
EP0642333B1 (de) 1998-06-24
EP0642333A4 (de) 1994-12-19
AU676161B2 (en) 1997-03-06
IL105498A0 (en) 1993-08-18
AU4110493A (en) 1993-11-18
JP3468519B2 (ja) 2003-11-17
WO1993020803A1 (en) 1993-10-28
US5846532A (en) 1998-12-08
JPH07505893A (ja) 1995-06-29
CN1091316A (zh) 1994-08-31
US5804188A (en) 1998-09-08

Similar Documents

Publication Publication Date Title
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE247974T1 (de) Kombinationtherapie mit einem tnf-bindendem protein zür behandlung von durch tnf verursachten erkrangungen
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
BR9507858A (pt) Aplicação de um composto inibidor de prolactina para preparar um medicamento para o tratamento de uma disfunção do sistema imunitário aplicação de um composto estimulador de prolactina para preparar um medicamento para o tratamento de uma disfunção do sistema imunitário aplicação de um composto estimulador de prolactina para preparar um medicamento para o tratamento de uma doença autoimunitária e pacote terapêutico
DE3485688D1 (de) Verfahren und vorrichtung zur behandlung von krankheiten.
ATE88097T1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
DE69328981D1 (de) Verfahren zur Behandlung von hyperproliferaktiven Gefässerkrankungen unter Verwendung von Rapamycin, eventuell in Kombination mit Mykophenolsäure
DE3888205D1 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
ATE30326T1 (de) Cyclische pentapeptide mit somatostatin antagonistischer wirksamkeit und verfahren zur behandlung von saeugetieren damit.
ATE138567T1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
DE69837322D1 (de) Verfahren zur therapeutischen verabreichung von anti-cd40l-mitteln
ATE167628T1 (de) Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE343398T1 (de) Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
EP0674905A3 (de) Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung.
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
DE3855236D1 (de) Verfahren zur behandlung der bösartigen und autoimmunen krankheiten beim menschen
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DE3878529D1 (de) Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen.
DE3864615D1 (de) Verfahren und anordnung zur behandlung von bei verbrennung schadstoffe freisetzendem holz, bzw. holzkohle.
EA200100385A1 (ru) Композиция и способ лечения нарушения гемостаза у субъекта (варианты)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties